Key facts
- This page summarizes Lorelei M. Skillman's Form 4 filing for Enfusion, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Jan 2023, 18:09.
Lorelei M. Skillman - 25 Jan 2023 Form 4 Insider Report for Enfusion, Inc.
- Reporting relationship
- Chief Mrktg. & Comm. Officer
- Issuer ticker
- N/A
- Reported as of
- 25 Jan 2023
- Net transaction value
- -$2,186
- SEC form
- 4
- Accepted by SEC
- 27 Jan 2023, 18:09:24 UTC
- Prior SEC filing
- 25 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Campobasso, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Lorelei M. Skillman filed Form 4 for Enfusion, Inc. on 27 Jan 2023.
Change
- Previous filing in this sequence was filed on 25 Jan 2023.
- Current net transaction value: -$2,186.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENFN
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +483
- Change %
- +1%
- Price
- $0.000000
- Shares after
- 46,697
- Date
- 25 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
ENFN
transaction
Class A Common Stock
Tax liability
- Transaction value
- $2,186
- Shares
- -184
- Change %
- -0.39%
- Price
- $11.88
- Shares after
- 46,513
- Date
- 25 Jan 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
Footnote F2
Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.